OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
39
Results
Show all
Save search
Copy query
Show results for
Unknown
(36)
Genomics
(3)
Organisms
Homo sapiens
(3)
Repository
EGA
(3)
Technology Type
Illumina HiSeq 2500, Illumina HiSeq 4000, ILLUMINA, NextSeq 500
(1)
Publication Date
Release Date
2024
(7)
2022
(7)
2021
(6)
2023
(5)
2020
(3)
2025
(2)
2019
(2)
2017
(2)
2016
(1)
2015
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Effectiveness of a Global Multidisciplinary Supportive and Educational Intervention in Thermal Resort on Anthropometric and Biological Parameters, and the Disease-Free Survival after Breast Cancer Treatment Completion (PACThe).
Not available
S-EPMC7222596
|
biostudies-literature
Cite
Is it important to adapt neoadjuvant chemotherapy to the visible clinical response? An open randomized phase II study comparing response-guided and standard treatments in HER2-negative operable breast cancer.
Not available
S-EPMC4350805
|
biostudies-literature
Cite
TERT
promoter status and gene copy number gains: effect on
TERT
expression and association with prognosis in breast cancer.
Not available
S-EPMC5652798
|
biostudies-literature
Cite
Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohort.
Not available
S-EPMC11647466
|
biostudies-literature
Cite
Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomes.
Not available
S-EPMC10937197
|
biostudies-literature
Cite
18
F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French study.
Not available
S-EPMC12781833
|
biostudies-literature
Cite
Factors associated with enrolment in clinical trials among women with early-stage breast cancer.
Not available
S-EPMC9271499
|
biostudies-literature
Cite
Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort.
Not available
S-EPMC11087908
|
biostudies-literature
Cite
Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France.
Not available
S-EPMC9478776
|
biostudies-literature
Cite
Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation.
Not available
S-EPMC10483331
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets